サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1206268

SMA・SCID向け新生児スクリーニングの世界市場の分析 (2023年)

Global Newborn Screening for SMA and SCID Market Research Report 2023
出版日: | 発行: QYResearch | ページ情報: 英文 84 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
SMA・SCID向け新生児スクリーニングの世界市場の分析 (2023年)
出版日: 2023年01月30日
発行: QYResearch
ページ情報: 英文 84 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のSMA・SCID向け新生児スクリーニングの市場規模は、2022年に1億2,921万米ドル、2029年には2億8,804万米ドルに達すると予測され、予測期間中 (2023年～2029年) に11.51%のCAGRで成長する見通しです。

当レポートでは、世界のSMA・SCID向け新生児スクリーニングの市場について分析し、種類別・用途別・地域別 (国別) の市場動向の見通し (2018年～2029年)、主要企業のプロファイルなどについて調査しております。

目次

第1章 調査概要

  • 調査範囲
  • 種類別の市場分析
    • 市場規模・成長率：種類別 (2018年・2022年・2029年)
    • 装置
    • キット
    • ソフトウェア
  • 用途別の市場
    • 市場シェア：用途別 (2018年・2022年・2029年)
    • SCID (脊髄性筋萎縮症) スクリーニング
    • SMA (重症複合免疫不全症) スクリーニング
  • 分析対象
  • 分析期間

第2章 世界の成長動向

  • 世界のSMA・SCID向け新生児スクリーニング市場の展望 (2018年～2029年)
  • SMA・SCID向け新生児スクリーニングの成長動向：地域別
  • SMA・SCID向け新生児スクリーニングの市場力学

第3章 主要企業別の競合情勢

  • SMA・SCID向け新生児スクリーニングの主要企業の収益
  • 市場シェア：企業の種類別 (ティア1、ティア2、ティア3)
  • 分析対象企業：SMA・SCID向け新生児スクリーニングの収益別のランキング
  • 世界のSMA・SCID向け新生児スクリーニング市場の集中度
  • SMA・SCID向け新生児スクリーニングの主要企業：本社・提供エリア
  • SMA・SCID向け新生児スクリーニングの主要企業：製品・ソリューション・サービス
  • 企業合併・買収 (M&A)、拡張計画

第4章 SMA・SCID向け新生児スクリーニング：種類別の内訳データ

  • 過去の市場規模：種類別 (2018年～2023年)
  • 市場規模の予測：種類別 (2024年～2029年)

第5章 SMA・SCID向け新生児スクリーニング：用途別の内訳データ

  • 過去の市場規模：用途別 (2018年～2023年)
  • 市場規模の予測：用途別 (2024年～2029年)

第6章 北米

  • 北米のSMA・SCID向け新生児スクリーニングの市場規模 (2018年～2029年)
  • 北米のSMA・SCID向け新生児スクリーニングの市場成長率：国別 (2018年・2022年・2029年)
  • 北米のSMA・SCID向け新生児スクリーニングの市場規模：国別 (2018年～2023年)
  • 北米のSMA・SCID向け新生児スクリーニングの市場規模：国別 (2024年～2029年)
  • 米国
  • カナダ

第7章 欧州

  • 欧州のSMA・SCID向け新生児スクリーニングの市場規模 (2018年～2029年)
  • 欧州のSMA・SCID向け新生児スクリーニングの市場成長率：国別 (2018年・2022年・2029年)
  • 欧州のSMA・SCID向け新生児スクリーニングの市場規模：国別 (2018年～2023年)
  • 欧州のSMA・SCID向け新生児スクリーニングの市場規模：国別 (2024年～2029年)
  • ドイツ
  • フランス
  • スペイン
  • スウェーデン
  • ノルウェー

第8章 他の国々 (RoW)

  • 他の国々 (RoW) のSMA・SCID向け新生児スクリーニングの市場規模 (2018年～2029年)
  • 他の国々 (RoW) のSMA・SCID向け新生児スクリーニングの市場成長率：国別 (2018年・2022年・2029年)
  • 他の国々 (RoW) のSMA・SCID向け新生児スクリーニングの市場規模：国別 (2018年～2023年)
  • 他の国々 (RoW) のSMA・SCID向け新生児スクリーニングの市場規模：国別 (2024年～2029年)
  • アジア
  • 中東・アフリカ

第9章 主要企業のプロファイル

  • Perkinelmer
  • Thermo Fisher
  • ImmunoIVD
  • Labsystems Diagnostics

第10章 アナリストの見解/結論

第11章 付録

図表

List of Tables

  • Table 1. Global Newborn Screening for SMA and SCID Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
  • Table 2. Key Players of Instruments
  • Table 3. Key Players of Kits
  • Table 4. Key Players of Software
  • Table 5. Global Newborn Screening for SMA and SCID Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
  • Table 6. Global Newborn Screening for SMA and SCID Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 7. Global Newborn Screening for SMA and SCID Market Size by Region (2018-2023) & (US$ Million)
  • Table 8. Global Newborn Screening for SMA and SCID Market Share by Region (2018-2023)
  • Table 9. Global Newborn Screening for SMA and SCID Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 10. Global Newborn Screening for SMA and SCID Market Share by Region (2024-2029)
  • Table 11. Newborn Screening for SMA and SCID Market Trends
  • Table 12. Newborn Screening for SMA and SCID Market Drivers
  • Table 13. Newborn Screening for SMA and SCID Market Challenges and Restraints
  • Table 14. Global Newborn Screening for SMA and SCID Revenue by Players (2021-2022) & (US$ Million)
  • Table 15. Global Newborn Screening for SMA and SCID Market Share by Players (2021-2022)
  • Table 16. Global Top Newborn Screening for SMA and SCID Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Screening for SMA and SCID as of 2022)
  • Table 17. Ranking of Global Top Newborn Screening for SMA and SCID Companies by Revenue (US$ Million) in 2022
  • Table 18. Global 3 Largest Players Market Share by Newborn Screening for SMA and SCID Revenue (CR3 and HHI) & (2021-2022)
  • Table 19. Global Key Players of Newborn Screening for SMA and SCID, Headquarters and Area Served
  • Table 20. Global Key Players of Newborn Screening for SMA and SCID, Product and Application
  • Table 21. Mergers & Acquisitions, Expansion Plans
  • Table 22. Global Newborn Screening for SMA and SCID Market Size by Type (2018-2023) & (US$ Million)
  • Table 23. Global Newborn Screening for SMA and SCID Revenue Market Share by Type (2018-2023)
  • Table 24. Global Newborn Screening for SMA and SCID Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 25. Global Newborn Screening for SMA and SCID Revenue Market Share by Type (2024-2029)
  • Table 26. Global Newborn Screening for SMA and SCID Market Size by Application (2018-2023) & (US$ Million)
  • Table 27. Global Newborn Screening for SMA and SCID Revenue Market Share by Application (2018-2023)
  • Table 28. Global Newborn Screening for SMA and SCID Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 29. Global Newborn Screening for SMA and SCID Revenue Market Share by Application (2024-2029)
  • Table 30. North America Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 31. North America Newborn Screening for SMA and SCID Market Size by Country (2018-2023) & (US$ Million)
  • Table 32. North America Newborn Screening for SMA and SCID Market Size by Country (2024-2029) & (US$ Million)
  • Table 33. Europe Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 34. Europe Newborn Screening for SMA and SCID Market Size by Country (2018-2023) & (US$ Million)
  • Table 35. Europe Newborn Screening for SMA and SCID Market Size by Country (2024-2029) & (US$ Million)
  • Table 36. Other Regions Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 37. Other Regions Newborn Screening for SMA and SCID Market Size by Country (2018-2023) & (US$ Million)
  • Table 38. Other Regions Newborn Screening for SMA and SCID Market Size by Country (2024-2029) & (US$ Million)
  • Table 39. Perkinelmer Company Details
  • Table 40. Perkinelmer Business Overview
  • Table 41. Perkinelmer Newborn Screening for SMA and SCID Product
  • Table 42. Perkinelmer Revenue in Newborn Screening for SMA and SCID Business (2021-2022) & (US$ Million)
  • Table 43. Thermo Fisher Company Details
  • Table 44. Thermo Fisher Business Overview
  • Table 45. Thermo Fisher Newborn Screening for SMA and SCID Product
  • Table 46. Thermo Fisher Revenue in Newborn Screening for SMA and SCID Business (2021-2022) & (US$ Million)
  • Table 47. ImmunoIVD Company Details
  • Table 48. ImmunoIVD Business Overview
  • Table 49. ImmunoIVD Newborn Screening for SMA and SCID Product
  • Table 50. ImmunoIVD Revenue in Newborn Screening for SMA and SCID Business (2021-2022) & (US$ Million)
  • Table 51. Labsystems Diagnostics Company Details
  • Table 52. Labsystems Diagnostics Business Overview
  • Table 53. Labsystems Diagnostics Newborn Screening for SMA and SCID Product
  • Table 54. Labsystems Diagnostics Revenue in Newborn Screening for SMA and SCID Business (2021-2022) & (US$ Million)
  • Table 55. Research Programs/Design for This Report
  • Table 56. Key Data Information from Secondary Sources
  • Table 57. Key Data Information from Primary Sources
  • Table 58. Authors List of This Report
  • Table 59. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

  • Figure 1. Product Picture of Newborn Screening for SMA and SCID
  • Figure 2. Global Newborn Screening for SMA and SCID Market Size Comparison by Type (2023-2029) & (US$ Million)
  • Figure 3. Global Newborn Screening for SMA and SCID Market Share by Type: 2022
  • Figure 4. Global Newborn Screening for SMA and SCID Market Share by Type: 2029
  • Figure 5. Instruments Features
  • Figure 6. Kits Features
  • Figure 7. Software Features
  • Figure 8. Global Newborn Screening for SMA and SCID Market Size by Application (2023-2029) & (US$ Million)
  • Figure 9. Global Newborn Screening for SMA and SCID Market Share by Application: 2022
  • Figure 10. Global Newborn Screening for SMA and SCID Market Share by Application: 2029
  • Figure 11. SCID Screening Case Studies
  • Figure 12. SMA Screening Case Studies
  • Figure 13. Newborn Screening for SMA and SCID Report Years Considered
  • Figure 14. Global Newborn Screening for SMA and SCID Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 15. Global Newborn Screening for SMA and SCID Market Size, (US$ Million), 2018 VS 2023 VS 2029
  • Figure 16. Global Newborn Screening for SMA and SCID Market Share by Region: 2022
  • Figure 17. Global Newborn Screening for SMA and SCID Market Share by Region: 2029
  • Figure 18. Global Newborn Screening for SMA and SCID Market Share by Players in 2022
  • Figure 19. The Top 3 Players Market Share by Newborn Screening for SMA and SCID Revenue in 2022
  • Figure 20. North America Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 21. North America Newborn Screening for SMA and SCID Market Share by Country (2018-2029)
  • Figure 22. United States Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 23. Canada Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 24. Europe Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 25. Europe Newborn Screening for SMA and SCID Market Share by Country (2018-2029)
  • Figure 26. Germany Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 27. France Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 28. Spain Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 29. Sweden Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 30. Norway Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 31. Other Regions Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. Other Regions Newborn Screening for SMA and SCID Market Share by Country (2018-2029)
  • Figure 33. Asia Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 34. MEA Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 35. Perkinelmer Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2021-2022)
  • Figure 36. Thermo Fisher Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2021-2022)
  • Figure 37. ImmunoIVD Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2021-2022)
  • Figure 38. Labsystems Diagnostics Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2021-2022)
  • Figure 39. Bottom-up and Top-down Approaches for This Report
  • Figure 40. Data Triangulation
  • Figure 41. Key Executives Interviewed
目次

The global Newborn Screening for SMA and SCID market was valued at US$ 129.21 million in 2022 and is anticipated to reach US$ 288.04 million by 2029, witnessing a CAGR of 11.51% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The major global companies of Newborn Screening for SMA and SCID include Perkinelmer, Thermo Fisher, ImmunoIVD, Labsystems Diagnostics, and etc. In 2022, the world's top two vendors accounted for approximately 84% of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Newborn Screening for SMA and SCID, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newborn Screening for SMA and SCID.

The Newborn Screening for SMA and SCID market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Newborn Screening for SMA and SCID market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Newborn Screening for SMA and SCID companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

  • Perkinelmer
  • Thermo Fisher
  • ImmunoIVD
  • Labsystems Diagnostics

Segment by Type

  • Instruments
  • Kits
  • Software

Segment by Application

  • SCID Screening
  • SMA Screening

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • Spain
  • France
  • Sweden
  • Norway
  • Other Regions
  • Asia
  • MEA

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Newborn Screening for SMA and SCID companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8: North America, Europe and Other Regions segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 9: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 10: The main points and conclusions of the report.

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Newborn Screening for SMA and SCID Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
    • 1.2.2 Instruments
    • 1.2.3 Kits
    • 1.2.4 Software
  • 1.3 Market by Application
    • 1.3.1 Global Newborn Screening for SMA and SCID Market Growth by Application: 2018 VS 2022 VS 2029
    • 1.3.2 SCID Screening
    • 1.3.3 SMA Screening
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Newborn Screening for SMA and SCID Market Perspective (2018-2029)
  • 2.2 Global Newborn Screening for SMA and SCID Growth Trends by Region
    • 2.2.1 Global Newborn Screening for SMA and SCID Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Newborn Screening for SMA and SCID Historic Market Size by Region (2018-2023)
    • 2.2.3 Newborn Screening for SMA and SCID Forecasted Market Size by Region (2024-2029)
  • 2.3 Newborn Screening for SMA and SCID Market Dynamics
    • 2.3.1 Newborn Screening for SMA and SCID Industry Trends
    • 2.3.2 Newborn Screening for SMA and SCID Market Drivers
    • 2.3.3 Newborn Screening for SMA and SCID Market Challenges and Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Newborn Screening for SMA and SCID Players by Revenue
    • 3.1.1 Global Top Newborn Screening for SMA and SCID Players by Revenue (2021-2022)
    • 3.1.2 Global Newborn Screening for SMA and SCID Revenue Market Share by Players (2021-2022)
  • 3.2 Global Newborn Screening for SMA and SCID Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players Ranking by Newborn Screening for SMA and SCID Revenue
  • 3.4 Global Newborn Screening for SMA and SCID Market Concentration Ratio
    • 3.4.1 Global Newborn Screening for SMA and SCID Market Concentration Ratio (CR3 and HHI)
    • 3.4.2 Global Top 3 Companies by Newborn Screening for SMA and SCID Revenue in 2022
  • 3.5 Global Key Players of Newborn Screening for SMA and SCID Head office and Area Served
  • 3.6 Global Key Players of Newborn Screening for SMA and SCID, Product and Application
  • 3.7 Mergers & Acquisitions, Expansion Plans

4 Newborn Screening for SMA and SCID Breakdown Data by Type

  • 4.1 Global Newborn Screening for SMA and SCID Historic Market Size by Type (2018-2023)
  • 4.2 Global Newborn Screening for SMA and SCID Forecasted Market Size by Type (2024-2029)

5 Newborn Screening for SMA and SCID Breakdown Data by Application

  • 5.1 Global Newborn Screening for SMA and SCID Historic Market Size by Application (2018-2023)
  • 5.2 Global Newborn Screening for SMA and SCID Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Newborn Screening for SMA and SCID Market Size (2018-2029)
  • 6.2 North America Newborn Screening for SMA and SCID Market Growth Rate by Country: 2018 VS 2022 VS 2029
  • 6.3 North America Newborn Screening for SMA and SCID Market Size by Country (2018-2023)
  • 6.4 North America Newborn Screening for SMA and SCID Market Size by Country (2024-2029)
  • 6.5 United States
  • 6.6 Canada

7 Europe

  • 7.1 Europe Newborn Screening for SMA and SCID Market Size (2018-2029)
  • 7.2 Europe Newborn Screening for SMA and SCID Market Growth Rate by Country: 2018 VS 2022 VS 2029
  • 7.3 Europe Newborn Screening for SMA and SCID Market Size by Country (2018-2023)
  • 7.4 Europe Newborn Screening for SMA and SCID Market Size by Country (2024-2029)
  • 7.5 Germany
  • 7.6 France
  • 7.7 Spain
  • 7.8 Sweden
  • 7.9 Norway

8 Other Regions

  • 8.1 Other Regions Newborn Screening for SMA and SCID Market Size (2018-2029)
  • 8.2 Other Regions Newborn Screening for SMA and SCID Market Growth Rate by Country: 2018 VS 2022 VS 2029
  • 8.3 Other Regions Newborn Screening for SMA and SCID Market Size by Country (2018-2023)
  • 8.4 Other Regions Newborn Screening for SMA and SCID Market Size by Country (2024-2029)
  • 8.5 Asia
  • 8.6 MEA

9 Key Players Profiles

  • 9.1 Perkinelmer
    • 9.1.1 Perkinelmer Company Details
    • 9.1.2 Perkinelmer Business Overview
    • 9.1.3 Perkinelmer Newborn Screening for SMA and SCID Introduction
    • 9.1.4 Perkinelmer Revenue in Newborn Screening for SMA and SCID Business (2021-2022)
  • 9.2 Thermo Fisher
    • 9.2.1 Thermo Fisher Company Details
    • 9.2.2 Thermo Fisher Business Overview
    • 9.2.3 Thermo Fisher Newborn Screening for SMA and SCID Introduction
    • 9.2.4 Thermo Fisher Revenue in Newborn Screening for SMA and SCID Business (2021-2022)
  • 9.3 ImmunoIVD
    • 9.3.1 ImmunoIVD Company Details
    • 9.3.2 ImmunoIVD Business Overview
    • 9.3.3 ImmunoIVD Newborn Screening for SMA and SCID Introduction
    • 9.3.4 ImmunoIVD Revenue in Newborn Screening for SMA and SCID Business (2021-2022)
  • 9.4 Labsystems Diagnostics
    • 9.4.1 Labsystems Diagnostics Company Details
    • 9.4.2 Labsystems Diagnostics Business Overview
    • 9.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Introduction
    • 9.4.4 Labsystems Diagnostics Revenue in Newborn Screening for SMA and SCID Business (2021-2022)

10 Analyst's Viewpoints/Conclusions

11 Appendix

  • 11.1 Research Methodology
    • 11.1.1 Methodology/Research Approach
    • 11.1.2 Data Source
  • 11.2 Author Details
  • 11.3 Disclaimer